Newsroom
June 3, 2020
TGI and Viracor Announce Transplant Advisory Board
Transplant Advisory Board to focus on trends and innovations in transplant diagnostics MANSFIELD, MA and Kansas City, MO, June 3,…
May 28, 2020
The American Journal of Transplantation Honors Transplant Genomics Advisor with 2020 Outstanding Article Award
MANSFIELD, Mass., May 28, 2020 – Transplant Genomics Inc. (TGI), the leader in bringing personalized diagnostics to transplant patients worldwide, announces…
May 21, 2020
Labs@Home™ Facilitates Outpatient Management of Kidney Transplants During COVID-19 – TruGraf® and Labs@Home reduce risks of surveillance biopsies during COVID-19
Mansfield, MA, May 21, 2020 — MANSFIELD, MA., Transplant Genomics, Inc. (“TGI”), Following the launch in April 2020 of Labs@Home in response to…
April 28, 2020
Dr. Peter Meintjes Joins Transplant Genomics as Chief Commercial Officer
Mansfield, MA, April 28, 2020 — MANSFIELD, MA., Eurofins -Transplant Genomics, Inc. (“TGI”), announces that Dr. Peter Meintjes has joined the…
April 15, 2020
Eurofins – Transplant Genomics Announces TRULO Registry Study to Evaluate Long-Term Clinical Outcomes in Patients Monitored with TruGraf® Testing
Mansfield, MA, April 15, 2020 — MANSFIELD, Mass., Eurofins – Transplant Genomics (“TGI”), a molecular diagnostics company committed to improving organ…
March 18, 2020
Remote Testing Options to Support Care for Kidney Transplant Recipients
March 18, 2020 — Eurofins is committed to supporting physicians in providing optimal care for their transplant patients. With the outbreak…
January 10, 2020
Transplant Genomics, Inc. Appoints Dr. John Holman as VP Medical Affairs
Mansfield, MA, January 10, 2020 — MANSFIELD, Mass., Transplant Genomics, Inc. (“TGI”), a molecular diagnostics company committed to improving organ transplant…
October 29, 2019
Transplant Genomics, Inc. Founders Awarded US Patent Covering Detection of “Silent” Sub-Clinical Rejection in Stable Kidney Transplant Recipients
Mansfield, MA, October 29, 2019 — MANSFIELD, Mass., Transplant Genomics, Inc. (“TGI”), a molecular diagnostics company committed to improving organ transplant…
October 11, 2019
Transplant Genomics, Inc. Confirms TruGraf® Will Receive Medicare Coverage Effective November 25, 2019
Mansfield, MA, October 11, 2019 — Transplant Genomics, Inc. (“TGI”), a molecular diagnostics company committed to improving organ transplant outcomes with non-invasive…
March 29, 2019
Medicare Issues Draft Local Coverage Determination (LCD) for Transplant Genomics’ TruGraf® Blood Test as Alternative to Surveillance Biopsies
Mansfield, MA, March 29, 2019 — Transplant Genomics Inc. (TGI) announces that Palmetto GBA has released a draft local coverage determination (LCD) for…